» Articles » PMID: 32568741

Prognostic Significance of Cardiac Injury in COVID-19 Patients with and Without Coronary Artery Disease

Abstract

Objective: COVID-19 is a disease with high mortality, and risk factors for worse clinical outcome have not been well-defined yet. The aim of this study is to delineate the prognostic importance of presence of concomitant cardiac injury on admission in patients with COVID-19.

Methods: For this multi-center retrospective study, data of consecutive patients who were treated for COVID-19 between 20 March and 20 April 2020 were collected. Clinical characteristics, laboratory findings and outcomes data were obtained from electronic medical records. In-hospital clinical outcome was compared between patients with and without cardiac injury.

Results: A total of 607 hospitalized patients with COVID-19 were included in the study; the median age was 62.5 ± 14.3 years, and 334 (55%) were male. Cardiac injury was detected in 150 (24.7%) of patients included in the study. Mortality rate was higher in patients with cardiac injury (42% vs. 8%; P < 0.01). The frequency of patients who required ICU (72% vs. 19%), who developed acute kidney injury (14% vs. 1%) and acute respiratory distress syndrome (71%vs. 18%) were also higher in patients with cardiac injury. In multivariate analysis, age, coronary artery disease (CAD), elevated CRP levels, and presence of cardiac injury [odds ratio (OR) 10.58, 95% confidence interval (CI) 2.42-46.27; P < 0.001) were found to be independent predictors of mortality. In subgroup analysis, including patients free of history of CAD, presence of cardiac injury on admission also predicted mortality (OR 2.52, 95% CI 1.17-5.45; P = 0.018).

Conclusion: Cardiac injury on admission is associated with worse clinical outcome and higher mortality risk in COVID-19 patients including patients free of previous CAD diagnosis.

Citing Articles

Effect of COVID-19 Pandemic on Acute Coronary Syndrome Clinical Practice Patterns: Findings from a Multicenter Clinician Survey in China.

Hu F, Zang M, Zheng L, Chen W, Guo J, Du Z Rev Cardiovasc Med. 2024; 23(11):362.

PMID: 39076199 PMC: 11269060. DOI: 10.31083/j.rcm2311362.


Mechanisms influencing the high prevalence of COVID-19 in diabetics: A systematic review.

Jain R, Mathew D Med Res Arch. 2024; 11(10).

PMID: 38933091 PMC: 11198970. DOI: 10.18103/mra.v11i10.4540.


The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems.

Golzardi M, Hromic-Jahjefendic A, Sutkovic J, Aydin O, Unal-Aydin P, Becirevic T Biomedicines. 2024; 12(4).

PMID: 38672267 PMC: 11048001. DOI: 10.3390/biomedicines12040913.


Echocardiographic Findings of Covid-19 Patients in Canton Sarajevo During the Third Wave of the Covid-19 Pandemic.

Sljivo A, Brigic L, Abdulkhaliq A, Dadic I, Reiter L, Sirucic I Mater Sociomed. 2024; 35(4):290-294.

PMID: 38380286 PMC: 10875953. DOI: 10.5455/msm.2023.35.290-294.


Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.

Wang S, Zhu R, Zhang C, Guo Y, Lv M, Zhang C PLoS One. 2023; 18(10):e0292021.

PMID: 37815980 PMC: 10564240. DOI: 10.1371/journal.pone.0292021.


References
1.
Lippi G, Lavie C, Sanchis-Gomar F . Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3):390-391. PMC: 7127395. DOI: 10.1016/j.pcad.2020.03.001. View

2.
Chen C, Yan J, Zhou N, Zhao J, Wang D . [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48(7):567-571. DOI: 10.3760/cma.j.cn112148-20200225-00123. View

3.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

4.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

5.
Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A . Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020; 80(4):388-393. PMC: 7102539. DOI: 10.1016/j.jinf.2020.02.016. View